A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL)

被引：3

作者：

Palomba, M. Lia ^{[1
]}

Ghione, Paola ^{[2
,3
]}

Patel, Anik R. ^{[4
]}

Deighton, Kevin ^{[5
]}

Jacobson, Caron ^{[6
]}

Nahas, Myrna ^{[4
]}

Jung, A. Scott ^{[4
]}

Hatswell, Anthony J. ^{[5
]}

Kanters, Steve ^{[7
]}

Limbrick-Oldfield, Eve ^{[7
]}

Wade, Sally W. ^{[8
]}

Snider, Julia Thornton ^{[4
]}

Neelapu, Sattva S. ^{[9
]}

Riberio, Maria Teresa ^{[10
]}

Gribben, John ^{[11
]}

Radford, John ^{[12
]}

Bobillo, Sabela ^{[13
]}

Ghesquieres, Herve ^{[14
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA

[3] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY USA

[4] Gilead Co, Kite, Santa Monica, CA USA

[5] Delta Hat, Nottingham, England

[6] Dana Farber Canc Ctr, Dept Med, Boston, MA USA

[7] RainCity Analyt, Vancouver, BC, Canada

[8] Wade Outcomes Res Consulting, Salt Lake City, UT USA

[9] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

[10] Portuguese Oncol Inst Porto, Porto, Portugal

[11] Univ London, Barts Canc Inst, Barts & London Sch Med, Queen Mary, London, England

[12] Christie NHS Fdn Trust, Manchester Canc Res Ctr & Manchester Acad Hlth Sc, Manchester, Lancs, England

[13] Hebron Inst Oncol VHIO, Expt Hematol, Barcelona, Spain

[14] Univ Claude Bernard Lyon 1, Dept Hematol, Ctr Hosp Lyon Sud, Pierre Benite, France

来源：

关键词：

D O I：

10.1182/blood-2021-147608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3543

引用

页数：6